Category: Endoscopic / Arthroscopic
Endoscopic / Arthroscopic
Covidien touts FDA clearance for its novel camera-equipped Kangaroo feeding tube designed to provide visualization for an otherwise blind procedure.
Medtech titan Covidien (NYSE:COV) received FDA clearance for its visual Kangaroo feeding tube, equipped with an endoscopic camera that allows physicians to see into the procedure in a new way.
Covidien reportedly agreed to a $100 million buyout of New Wave Surgical and its D-Help device, designed to keep endoscope lenses clear during surgeries.
Covidien (NYSE:COV) reportedly paid $100 million to acquire New Wave Surgical and its medical device for keeping endoscope lenses clear during surgeries.
Covidien's Barrx RF ablation system bests watchful waiting in helping to curb the progression of Barrett's esophagus, a condition that can lead to esophageal cancer.
Invendo Medical says it raised about $28 million for its Invendoscope single-use colonoscopy system.
Invendo Medical said it raised a $28 million (€20.3 million) funding round for its single-use colonoscopy system led by new backer Xeraya Capital.
Kissing, Germany, and New York-based Invendo said a German Family Office also joined the round, which included existing investors TVM Capital, Wellington Partner, 360° Capital and its founders.
Covidien closes the $860 million acquisition of Given Imaging and its PillCam capsule endoscope.
Covidien (NYSE:COV) said it closed the buyout of Given Imaging and its PillCam imaging device for about $860 million, net of cash and investments.
EndoChoice can market its Fuse endoscopy system in Canada now that Health Canada has given the company clearance to sell the device.
EndoChoice said it won a marketing license in Canada for its Fuse endoscopy system.
The Fuse endoscope features 3 small cameras that provide a 330-degree view, nearly double the range of typical colonoscopy devices.
The Fuse device won FDA 510(k) clearance in the U.S. in June 2013.
Avantis brings in a $4.8 million debt round for its Third Eye colonoscopy endoscope.
Avantis Medical Systems said it brought in $4.8 million of a hoped-for $10.6 million debt round.
Sunnyvale, Calif.-based Avantis makes catheter-based endoscopic devices designed to detect and treat and gastrointestinal cancers, according to its website. It's flagship product is the Third Eye "retrospect" for colonoscopies.